Form 8-K - Current report:
SEC Accession No. 0001558370-22-011491
Filing Date
2022-08-02
Accepted
2022-08-01 17:44:05
Documents
15
Period of Report
2022-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmbr-20220727x8k.htm   iXBRL 8-K 40732
2 EX-4.1 tmbr-20220727xex4d1.htm EX-4.1 147705
3 EX-10.1 tmbr-20220727xex10d1.htm EX-10.1 22784
  Complete submission text file 0001558370-22-011491.txt   370289

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmbr-20220727.xsd EX-101.SCH 3729
5 EX-101.DEF tmbr-20220727_def.xml EX-101.DEF 2725
6 EX-101.LAB tmbr-20220727_lab.xml EX-101.LAB 17262
7 EX-101.PRE tmbr-20220727_pre.xml EX-101.PRE 10072
9 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20220727x8k_htm.xml XML 4860
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 221126072
SIC: 2834 Pharmaceutical Preparations